This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • News trends
  • /
  • Targeted therapies in HER2 positive breast cancer
Insight

Targeted therapies in HER2 positive breast cancer

Read time: 6 mins
Last updated:23th Aug 2019
Published:1st Aug 2019
Source: Medthority
This is the second of a four-part series looking at the latest trends in treatments developed for breast cancer. Here we highlight the current and latest therapies for the HER2 positive subtype of breast cancer, including trastuzumab and next generation treatments such as margetuximab.
Register now for full access to medthority.com